Carriers of the A allele were determined to have a 2.9-fold greater risk of developing dose-related atorvastatin ADRs ( p = 0.016) (Mirosevic Skvrce et al., 2015)
The cardioprotective effects of GLP-1 agonists could be a significant advantage for RA patients, who are at increased risk for heart disease. As that research continues, other questions that require interrogation involve the duration of therapy and whether GLP-1 receptor agonism will yield adverse events over the long term
citizens or permanent residents of the United States and for most agencies, less than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these (some agencies allow majority VC-owned startups)
Emphasis is placed on clinical screening, controlled titration, and ongoing monitoring to align outcomes with safety parameters
6 Multiple microbes in both the small and large intestines can convert dietary L-carnitine into GBB, but relatively few can transform GBB into TMA.13 The GBB-to-TMA conversion is much higher in omnivores than in vegans and vegetarians, likely because of differences in the gut microbiota, although this aspect of the L-carnitine-to-TMAO pathway is not fully understood
A major concern with GLP-1 agonists is the risk of weight regain after stopping treatment
